Droperidol Gets Second-Line, Narrowed Indication Due To Arrhythmia Risk
Executive Summary
Updated labeling for Akorn's Inapsine and droperidol generics restricts the drug to second-line use for a narrowed indication due to the risk of fatal cardiac arrhythmias